Povetacicept
VX24-AIS-D10
Phase 3 small_molecule active
Quick answer
Povetacicept for Primary Membranous Nephropathy is a Phase 3 program (small_molecule) at Vertex Pharmaceuticals (Australia) Pty. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vertex Pharmaceuticals (Australia) Pty.
- Indication
- Primary Membranous Nephropathy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active